Black Friday shoppers leave a Best Buy store in Washington, DC, on November 26, 20221. Nicholas Kamm | AFP | Getty Images Best Buy said Wednesday that it will offer an expanded collection of hearing products and services this fall after federal regulators said they would begin allowing sales of over-the-counter hearing devices. By fall, …
Best Buy to sell OTC hearing aid devices after FDA regulation Read More »
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 am ET. Here’s a recap of Monday’s key moments: Oil’s decline is good news We want confirmation that inflation’s peaked Quick mentions: JNJ, LLY, LIN Disney’s real problem is its balance sheet 1. Oil’s decline is good news Stocks …
4 takeaways from the Investing Club’s ‘Morning Meeting’ on Monday Aug. 15 Read More »
Britain has become the first country in the world to approve Moderna’s bivalent Covid-19 vaccine, which targets both the original strain of the virus and the newer Omicron variant. Long Visual Press | Universal Images Group | Getty Images LONDON — Britain on Monday became the first country in the world to approve a dual …
UK becomes first country to approve Moderna’s dual Covid-19 vaccine Read More »
Shares of GSK, Sanofi and Haleon all sold off sharply this week, shedding tens of billions in market value, amide investor fear over potential US litigation charges focused on popular heartburn drug Zantac. This has been a known issue bubbling in the background for years but investor concern exploded this week in the lead-up to …
Pharma stocks crater as investors brace for litigation charges Read More »
A CVS Pharmacy store is seen in the Manhattan borough of New York City, New York. Shannon Stapleton | Reuters CVS said Wednesday that it plans to acquire or take a stake in a primary-care company by the end of the year, as competition heats up with Amazon and Walgreens. CEO Karen Lynch said on …
CVS says it plans to get into primary care by year end Read More »
Now is the time to buy biotech company Kymera Therapeutics as shares could jump more than 75% from here, Goldman Sachs said. Analyst Chris Shibutani initiated coverage of Kymera with a buy rating and a $40 price target, saying in a note to clients that shares are currently trading at an attractive entry for investors. …
Goldman says buy this ground-breaking biotech stock poised to rally 75% from here Read More »
People walk by a CVS Pharmacy store in the Manhattan borough of New York City. Shannon Stapleton | Reuters CVS Health on Wednesday lifted its earnings outlook for the year, after beating Wall Street’s expectations for the fiscal second quarter. The health-care company said it now expects adjusted earnings per share for the full year …
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. Jennifer Lorenzini | Reuters Pfizer’s second-quarter revenue and profit beat Wall Street expectations, driven by sales of its Covid-19 vaccine and its antiviral treatment Paxlovid. Pfizer booked $27.7 billion in revenue, a 47% increase over the …
Morgan Stanley is urging investors to resist putting their money to work in stocks despite the market’s post-Fed-decision jump. Mike Wilson, the firm’s chief US equity strategist and chief investment officer, said he believes Wall Street’s excitement over the idea that interest rate hikes may slow sooner than expected is premature and problematic. “The market …
Market jump after Fed hike is ‘trap,’ Morgan Stanley warns investors Read More »
3M announced Tuesday that it will spin off its health care business into a separate publicly traded company. The new business will focus on wound and oral care, healthcare IT and biopharma filtration, the material science company said in a release. That includes products like its bandages, skin adhesives, oral aligners, air purifiers and optical …
3M will spin off its health care business into a new public company Read More »